Traditional methods of treating prostate cancer, which attack the whole prostate with radiation or surgery, often come at the cost of the patient’s continence or erectile function.
A new, less-invasive technology for getting rid of prostate cancer, known as the “nanoknife”, targets only the site of the cancer, destroying the cells of the cancer without the structures surrounding it, including the erectile and urethral nerves.
In a study of 25 patients, in 76 per cent of cases the cancer had not returned after eight months. None of them developed incontinence or impotence.